Total Payments
$8,306
2024 Payments
$778.05
Companies
39
Transactions
472
Medicare Patients
758
Medicare Billing
$50,140
Payment Breakdown by Category
Food & Beverage$7,769 (93.5%)
Education$537.73 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,769 | 448 | 93.5% |
| Education | $537.73 | 24 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,243 | 71 | $0 (2024) |
| Astellas Pharma US Inc | $1,042 | 49 | $0 (2024) |
| PFIZER INC. | $656.52 | 60 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $492.36 | 34 | $0 (2019) |
| TherapeuticsMD, Inc. | $402.13 | 26 | $0 (2022) |
| Avion Pharmaceuticals | $395.48 | 30 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $333.88 | 21 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $303.08 | 14 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $286.05 | 9 | $0 (2023) |
| Myovant Sciences Inc. | $257.70 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $778.05 | 33 | Astellas Pharma US Inc ($209.00) |
| 2023 | $1,126 | 50 | MAYNE PHARMA COMMERCIAL LLC ($286.05) |
| 2022 | $1,413 | 79 | MAYNE PHARMA INC. ($208.42) |
| 2021 | $1,402 | 53 | Astellas Pharma US Inc ($304.94) |
| 2020 | $497.51 | 33 | Astellas Pharma US Inc ($123.59) |
| 2019 | $1,133 | 77 | AbbVie, Inc. ($177.44) |
| 2018 | $953.84 | 67 | AMAG Pharmaceuticals, Inc. ($159.99) |
| 2017 | $1,003 | 80 | Vertical Pharmaceuticals, LLC ($276.48) |
All Payment Transactions
472 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Womens Health | ||||||
| 12/05/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Biological | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: OB/GYN | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Oncology | ||||||
| 10/21/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Biological | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neurology | ||||||
| 09/04/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: OB/GYN | ||||||
| 08/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Biological | ||||||
| 07/03/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: VACCINES | ||||||
| 06/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $25.71 | General |
| 05/30/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: HORMONE THERAPY | ||||||
| 05/13/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $28.14 | General |
| 05/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Biological | ||||||
| 04/22/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $24.60 | General |
| 04/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Oncology | ||||||
| 03/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 184 | 186 | $29,070 | $10,903 |
| 2022 | 6 | 178 | 181 | $27,635 | $11,285 |
| 2021 | 6 | 175 | 184 | $30,219 | $13,459 |
| 2020 | 8 | 221 | 229 | $38,227 | $14,494 |
Total Patients
758
Total Services
780
Medicare Billing
$50,140
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 28 | 28 | $11,760 | $3,984 | 33.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 39 | 39 | $2,145 | $1,848 | 86.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 40 | 40 | $2,600 | $1,663 | 64.0% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 28 | 28 | $5,040 | $1,615 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $2,925 | $1,165 | 39.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $3,900 | $548.34 | 14.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 20 | 20 | $700.00 | $79.61 | 11.4% |
| 77067 | Screening mammography | Office | 2022 | 24 | 24 | $10,080 | $3,451 | 34.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 50 | 50 | $2,750 | $2,368 | 86.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 49 | 49 | $3,185 | $2,091 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $3,100 | $1,411 | 45.5% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 24 | 24 | $4,320 | $1,384 | 32.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 14 | 14 | $4,200 | $579.60 | 13.8% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 29 | 29 | $12,180 | $4,322 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 28 | $4,320 | $2,241 | 51.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 43 | 43 | $2,365 | $2,076 | 87.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 44 | 44 | $2,820 | $1,902 | 67.5% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 29 | 29 | $5,220 | $1,759 | 33.7% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 11 | 11 | $3,314 | $1,158 | 34.9% |
| 77067 | Mammography of both breasts | Office | 2020 | 30 | 30 | $12,600 | $4,554 | 36.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 46 | 46 | $2,530 | $2,173 | 85.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 46 | 46 | $2,760 | $2,013 | 72.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 33 | $4,950 | $1,945 | 39.3% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 30 | 30 | $5,400 | $1,802 | 33.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 13 | 13 | $3,822 | $1,094 | 28.6% |
About Dr. George Heading, MD
Dr. George Heading, MD is a Obstetrics & Gynecology healthcare provider based in Stamford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548364532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Heading, MD has received a total of $8,306 in payments from pharmaceutical and medical device companies, with $778.05 received in 2024. These payments were reported across 472 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,769).
As a Medicare-enrolled provider, Heading has provided services to 758 Medicare beneficiaries, totaling 780 services with total Medicare billing of $50,140. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Stamford, CT
- Active Since 09/11/2006
- Last Updated 10/27/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1548364532
Products in Payments
- ORILISSA (Drug) $491.18
- MYFEMBREE (Drug) $418.17
- GEMTESA (Drug) $411.51
- LO LOESTRIN FE (Drug) $389.58
- MYRBETRIQ (Drug) $370.31
- PREMARIN (Drug) $324.24
- Veozah (Drug) $310.28
- Balcoltra (Drug) $290.95
- DIVIGEL (Drug) $274.39
- Orilissa (Drug) $261.36
- ANNOVERA (Drug) $257.49
- INTRAROSA (Drug) $255.83
- OVA1 (Device) $250.69
- Osphena (Drug) $216.60
- Cologuard Collection Kit (Device) $180.21
- PREMARIN ORALS (Drug) $161.58
- CORVITE FE W QUATREFOLIC (Drug) $140.43
- Kyleena (Drug) $128.19
- CitraNatal (Drug) $125.16
- Mirena (Drug) $103.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Stamford
Daniel Cibulsky, Md, MD
Obstetrics & Gynecology — Payments: $20,200
Obstetrics & Gynecology $20,200
Gary Besser, Md, MD
Obstetrics & Gynecology — Payments: $8,752
Obstetrics & Gynecology $8,752
Patrick Cahill, D.o, D.O
Obstetrics & Gynecology — Payments: $7,951
Obstetrics & Gynecology $7,951
Astrid Hoffmann-Olsen, Md, MD
Obstetrics & Gynecology — Payments: $7,915
Obstetrics & Gynecology $7,915
Dr. Joel Evans, Md, MD
Obstetrics & Gynecology — Payments: $7,564
Obstetrics & Gynecology $7,564
David Weinstein, Md, MD
Obstetrics & Gynecology — Payments: $7,165
Obstetrics & Gynecology $7,165